Par Drugs and Chemicals Limited
  • Home
  • About Us
    • Corporate Profile
    • Board of Directors
    • Milestones
    • Awards and Appreciations
    • Research & Development
    • Recognitions & Certifications
  • Products
    • Magnesium Salts
      • Magnesium Hydroxide
      • Magnesium Trisilicate
      • Magnesium Carbonate
      • Light Magnesium Oxide
      •  Magnesium Oxide Heavy
      •  Magnesium Oxide USP
    • Dried Aluminum Hydroxide Gel
    • Blended
      • Magaldrate
      • Magnesium Aluminium Silicate Hydrated
      • Alma Gate
      • Hydrotelcite
      • Aluminium Hydroxide Magnesium Carbonate Co-Dried Gel
      • Aluminium Magnesium Silicate BP
    • Sodium Aluminium Silicate
    • Precipitated Silica
    • Magnesium Silicate
    • Amorphous
    • Collodial Silicon Dioxide
    • Sucralfate USP
  • Manufacturing
    • Registered Office
    • Manufacturing Site
    • Laboratory
  • Investors
    • Announcement & Notice
    • Investor Contact
    • Financials
      • Sales Profile
      • 10 Year's Highlight
      • Financial Statements
    • Annual Reports & Retuns
    • Corporate Governance Report
    • Share Holding Pattern
    • Compliance Certificate
    • Secretarial Compliance Report
    • Committee
    • Grievance Redressal
    • Familiarisation Programme
    • Dividend
    • Policies
    • CSR
  • Inquiry
  • Contact Us
  • Prospectus
    • Prospectus
Sitemap

Others

  • Home
  • Others
  • List of Creditors as on 31-03-2021
  • List of Creditors

Investors

  •  Announcement & Notice
  •  Investor's Contact
  •  Financials
    •  Sales Profile
    • 10 Year's Highlight
    • Financial Statements
  •  Annual Reports & Retuns
  •  Corporate Governance Report
  •  Secretarial Compliance Report
  •  Share Holding Pattern
  •  Compliance Certificate
  •  Committee
  •  Grievance Redressal
  •  Familiraisation Programme
  •  Dividend
  •  Policies
  •  CSR
    • CSR Policy
    • CSR

Copyright © Par Drugs and Chemical Limited 2019. All rights reserved.

Created by: PixelWorks Web Design